Courageous. Focused. Passionate.

Harnessing the Power of Nature With Precision Science™

Cancer continues to inflict devastating consequences worldwide. Bexion is committed to conquering cancer and to deliver on our commitment, we have assembled a world class leadership team to advance our innovative, targeted cancer therapy platform. Targeted therapy brings significant potential to the fight against cancer and we are relentless in our pursuit to realize this potential.


– Our Platform

An innovative, targeted approach to treating cancer

Our treatment specifically targets unique features of cancer cells, including externalized phosphatidylserine and tumor cell lysosomes by utilizing a small lysosomal protein known as Saposin C.

Learn More

– Our Pipeline

A Pipeline-in-a-Product asset with potential for multiple indications

BXQ-350 is the foundation of our pipeline. Early clinical results have shown a strong safety and tolerability profile.

Learn More

– clinical trials


Our clinical trials are regulated by the Food and Drug Administration (FDA) in the United States and by similar regulatory agencies worldwide.

Learn More


Bexion Resources


Learn More
View All Resources


    Press Release

    New Segment of Advancements to Focus on Breakthroughs in Targeted Cancer Cell Treatment

    April 12, 2021

    Jupiter, FL— The award-winning series, Advancements with Ted Danson, will focus on an innovative, targeted approach to treating a range of diseases during 3Q/2021. Check local listings for more information. The diseases for which medicine offers few effective options – advanced cancer (or even early-stage cancer for certain types), neurodegenerative diseases and autoimmune diseases – persist because ... Read More

      Press Release

      Bexion Pharmaceuticals Announces the Addition of Olivia F. Kirtley to Board of Directors

      February 22, 2021

      FOR IMMEDIATE RELEASE Covington, KY February 22, 2021 Bexion Pharmaceuticals, Inc. announced today that it has added Olivia F. Kirtley to its Board of Directors. Ms. Kirtley, a Certified Public Accountant and Chartered Global Management Accountant, is a business consultant on strategic, risk and corporate governance issues. She brings to Bexion extensive experience as ... Read More

      View All Media